A Safety and Immunogenicity Trial in Adults 65 Years of Age or Over to Prevent Influenza
Clinical trial NCT00706732 · COMPLETED
Trial details
- NCT number
- NCT00706732
- Sponsor
- AlphaVax, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2008-09-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.